[Sponsored] In a recent interview, Esperion President and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases.
The post Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health appeared first on MedCity News.
